WO2025219892 - NOVEL MIRNAS FOR TREATING OSTEOARTHRITIS, COMBINATIONS THEREOF, COMPOSITIONS COMPRISING SAID MIRNAS AND RELATED METHODS
National phase entry is expected:
Publication Number
WO/2025/219892
Publication Date
23.10.2025
International Application No.
PCT/IB2025/053968
International Filing Date
15.04.2025
Title **
[English]
NOVEL MIRNAS FOR TREATING OSTEOARTHRITIS, COMBINATIONS THEREOF, COMPOSITIONS COMPRISING SAID MIRNAS AND RELATED METHODS
[French]
NOUVEAUX MIARN POUR LE TRAITEMENT DE L'ARTHROSE, COMBINAISONS DE CEUX-CI, COMPOSITIONS COMPRENANT LESDITS MIARN ET PROCÉDÉS ASSOCIÉS
Applicants **
DHARMA BIOSCIENCE LLC
CONSEJO NACIONAL DE INVESTIGACIONES CIENTÍFICAS Y TÉCNICAS (CONICET)
UNIVERSIDAD NACIONAL DE CUYO
Inventors
CESCOTTI, Franco Gabriel
TOPOL, Gaston Andres
CROCI RUSSO, Diego Omar
GARCIA, Pablo Alfredo
Priority Data
63/635,863
18.04.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
EPO
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1939 | |
| EPO | Filing, Examination, Granting | 8413 | |
| Japan | Filing, Examination, Granting | 2025 | |
| South Korea | Filing, Examination, Granting | 1736 | |
| USA | Filing, Examination, Granting | 5940 |
Total:
20,053
Contact Us
Abstract[English]
The present disclosure refers to novel RNA molecules based on miRNAs which are useful for the treatment of osteoarthritis (OA), by modulating the expression of OA-related genes, as well as combinations and compositions comprising them, and methods related thereto.[French]
La présente divulgation concerne de nouvelles molécules d'ARN à base de miARN qui sont utiles pour le traitement de l'arthrose (OA), par modulation de l'expression de gènes liés à l'arthrose, ainsi que des combinaisons et des compositions les comprenant, et des procédés associés.